Inventor · disambiguated record
Mahadeo Vasant Mahadik
Also filed as: MAHADIK MAHADEO VASANT
7 granted patents·3 pending applications·0 citations·filing 2018–2025
74Inventor score
Technology areasA61K
Top patents by PatentIndex Score
10 records- 0186US12151020B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2024·Granted Nov 26, 2024·0 cites·14 claims
- 0283US2025375373A1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0382US11938217B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2023·Granted Mar 26, 2024·0 cites·19 claims
- 0479US12370190B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2024·Granted Jul 29, 2025·0 cites·18 claims
- 0575US12383491B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateAZURITY PHARMACEUTICALS INC·Filed 2021·Granted Aug 12, 2025·0 cites·17 claims
- 0674US12097197B2Stable liquid compositions of netupitant and palonosetronSLAYBACK PHARMA LLC·Filed 2022·Granted Sep 24, 2024·0 cites·24 claims
- 0772US2025312337A1Stable liquid compositions of netupitant and palonosetronAZURITY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0871US11110054B2Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Sep 7, 2021·0 cites·10 claims
- 0971US10456354B1Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolateSLAYBACK PHARMA LLC·Filed 2018·Granted Oct 29, 2019·0 cites·21 claims
- 1062US2024156829A1Stable Antiemetic Emulsions for Parenteral AdministrationSLAYBACK PHARMA LLC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mahadeo Vasant Mahadik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →